ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Puerto Rico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IRELIS RAMIREZ MD

Neurology

4,138

$415K

537
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 34%

$100
Average prescription price

Avg: $113

JOSE ACEVEDO MD

Neurology

4,125

$524K

584
432 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 34%

$127
Average prescription price

Avg: $113

RENE SANCHEZ-BORRERO M.D.

Neurology

4,112

$394K

523
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 34%

$96
Average prescription price

Avg: $113

IVONNE DE L FRAGA BERRIOS MD

Neurology

3,851

$511K

373
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 34%

$133
Average prescription price

Avg: $113

EDGARDO COLON-ZAVALA M.D.

Neurology

3,770

$302K

344
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 34%

$80
Average prescription price

Avg: $113

PORFIRIO RODRIGUEZ MD

Neurology

3,559

$208K

689
581 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 34%

$58
Average prescription price

Avg: $113

OMAR CARDONA-GARCIA MD

Neurology

3,175

$258K

441
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 34%

$81
Average prescription price

Avg: $113

JOSE DIAZ PIMENTEL MD

Neurology

3,133

$206K

962
884 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 34%

$66
Average prescription price

Avg: $113

MARIA CRUZ-LARTIGAUT MD

Neurology

3,100

$367K

380
253 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 34%

$119
Average prescription price

Avg: $113

RICARDO VILLALOBOS M.D.

Neurology

2,973

$231K

528
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 34%

$78
Average prescription price

Avg: $113

LOURDES BENES M.D.

Neurology

2,726

$182K

354
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 34%

$67
Average prescription price

Avg: $113

HECTOR MIRANDA DELGADO MD

Neurology

2,696

$298K

218
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 34%

$111
Average prescription price

Avg: $113

FERNANDO SANTIAGO M.D.

Neurology

2,615

$297K

325
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 34%

$113
Average prescription price

Avg: $113

HORACIO DAUBON DEL VALLE M.D.

Neurology

2,578

$295K

423
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 34%

$114
Average prescription price

Avg: $113

MARITZA ARROYO-MUNIZ MD

Neurology

2,463

$341K

202
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 34%

$139
Average prescription price

Avg: $113

DAMARIS TORRES-BERRIOS MD

Neurology

2,451

$289K

244
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 34%

$118
Average prescription price

Avg: $113

GISHLAINE ALFONSO MD

Neurology

2,275

$400K

254
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 34%

$176
Average prescription price

Avg: $113

LUIS RIVERA-RAMOS M.D.

Neurology

2,267

$203K

381
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 34%

$90
Average prescription price

Avg: $113

BRISEIDA FELICIANO M.D.

Neurology

2,058

$126K

334
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 34%

$61
Average prescription price

Avg: $113

ENRIQUE RODRIGUEZ-OLAVERRI MD

Neurology

2,033

$235K

231
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 34%

$116
Average prescription price

Avg: $113

JANET PEREZ CHIESA M.D.

Neurology

1,942

$148K

319
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 34%

$76
Average prescription price

Avg: $113

TOMAS HERNANDEZ-ORTIZ M.D.; M.P.H.

Neurology

1,667

$205K

193
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 34%

$123
Average prescription price

Avg: $113

RICARDO ALVARADO-MELENDEZ M.D.

Neurology

1,646

$152K

194
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 34%

$92
Average prescription price

Avg: $113

KARINA RODRIGUEZ-JUAN MD

Neurology

1,417

$108K

173
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 34%

$77
Average prescription price

Avg: $113

DRA-IRIS A ACEVEDO MARTY P S C

Neurology

1,302

$122K

172
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 34%

$94
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank